Philippe Calais

Chief Executive Officer at TransCode Therapeutics, Inc.

Presenter

Philippe P. Calais, Pharm D, PhD. is the CEO and chairman of the board of the US-based Phase 2 clinical stage oncology Transcode Therapeutics (Nasdaq: RNAZ).With extensive biotech and Pharma experience, Philippe has led several private and publicly traded companies both in Europe and North America since 2000, with responsibilities spanning across all functions of the drug development chain from discovery through commercialization, partnership, fund raising and IPOs He also served as head of global strategic marketing for anti-infectives at Hofmann-La Roche.